List of works - Gilbert Verbeken

A bacteriophage journey at the European Medicines Agency

scientific article published on 10 December 2015

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium

scientific article published on 7 April 2015

Actin dynamics regulate immediate PAR-2-dependent responses to acute epidermal permeability barrier abrogation

scientific article published on 7 December 2010

Bacteriophage Production in Compliance with Regulatory Requirements

scientific article published in January 2018

Beware of the commercialization of human cells and tissues: situation in the European Union

scientific article

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

article

Biosimilars and market access: a question of comparability and costs? ⬇️

scientific article published on January 17, 2012

Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems

scientific article published on 20 September 2013

Call for a dedicated European legal framework for bacteriophage therapy.

scientific article published on 06 February 2014

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

scientific article

Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

article

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

scientific article published on 25 September 2019

European regulatory conundrum of phage therapy

scientific article

Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures

scientific article

Experimental phage therapy of burn wound infection: difficult first steps

scientific article

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

scientific article published on 5 April 2018

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety

scientific article published on 11 March 2011

Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi

scientific article published on March 2011

Human cells and tissues: the need for a global ethical framework

scientific article

Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting

scientific article published on 11 April 2013

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center

scientific article

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

scientific article published on 17 April 2012

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

scientific article published on 18 October 2013

Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservation.

scientific article published on 10 February 2010

Quality and safety requirements for sustainable phage therapy products

scientific article published on 14 January 2015

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

scientific article

Real-time three-dimensional imaging of epidermal splitting and removal by high-definition optical coherence tomography.

scientific article published on October 2014

Recellularizing of human acellular dermal matrices imaged by high-definition optical coherence tomography.

scientific article

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

scientific article

Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)

scientific article

Stability of bacteriophages in burn wound care products.

scientific article

Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger

scientific article published on 27 August 2020

Taking bacteriophage therapy seriously: a moral argument

scientific article

The Magistral Phage

scientific article published on 6 February 2018

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

scientific article published on 10 November 2010

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

scientific article published on 03 September 2020

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report.

scientific article published on 4 June 2017

List of works by Gilbert Verbeken

A bacteriophage journey at the European Medicines Agency

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium

Actin dynamics regulate immediate PAR-2-dependent responses to acute epidermal permeability barrier abrogation

Bacteriophage Production in Compliance with Regulatory Requirements

Beware of the commercialization of human cells and tissues: situation in the European Union

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

Biosimilars and market access: a question of comparability and costs? ⬇️

Business oriented EU human cell and tissue product legislation will adversely impact Member States' health care systems

Call for a dedicated European legal framework for bacteriophage therapy.

Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii

Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations

Development of a qPCR platform for quantification of the five bacteriophages within bacteriophage cocktail 2 (BFC2)

European regulatory conundrum of phage therapy

Evaluation of a microbiological screening and acceptance procedure for cryopreserved skin allografts based on 14 day cultures

Experimental phage therapy of burn wound infection: difficult first steps

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.

Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety

Glycerol treatment as recovery procedure for cryopreserved human skin allografts positive for bacteria and fungi

Human cells and tissues: the need for a global ethical framework

Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting

Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

Potential release of aluminum and other metals by food-grade aluminum foil used for skin allograft cryo preservation.

Quality and safety requirements for sustainable phage therapy products

Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials

Real-time three-dimensional imaging of epidermal splitting and removal by high-definition optical coherence tomography.

Recellularizing of human acellular dermal matrices imaged by high-definition optical coherence tomography.

Selection and characterization of a candidate therapeutic bacteriophage that lyses the Escherichia coli O104:H4 strain from the 2011 outbreak in Germany

Stability of Staphylococcus aureus phage ISP after freeze-drying (lyophilization)

Stability of bacteriophages in burn wound care products.

Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger

Taking bacteriophage therapy seriously: a moral argument

The Magistral Phage

The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?

The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report.